Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01740830
Other study ID # MECU2012-003
Secondary ID
Status Completed
Phase N/A
First received November 26, 2012
Last updated June 1, 2013
Start date June 2012
Est. completion date October 2012

Study information

Verified date June 2013
Source Hasselt University
Contact n/a
Is FDA regulated No
Health authority Belgium: Ethics Committee
Study type Interventional

Clinical Trial Summary

The current study investigates the effects of tDCS in patients with multiple sclerosis (MS). The investigators hypothesize that anodal tDCS will increase motor performance in patients with MS.


Recruitment information / eligibility

Status Completed
Enrollment 31
Est. completion date October 2012
Est. primary completion date October 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- at least 18 years old

- male and female

Exclusion Criteria:

- relapse in the last 3 months

- when not suitable for tDCS (screening)

- if TMS measures can not be completed

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Transcranial Direct Current Stimulation (tDCS) (Neuroconn DC-stimulator)
The anode will be fixed over the primary motor cortex. The cathode will be fixed over the contralateral supraorbital region.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Hasselt University

Outcome

Type Measure Description Time frame Safety issue
Primary Motor performance on a unimanual sequence learning task Patients were instructed to perform a unimanual sequence-learning task consisting of sequential finger presses. The following parameters were measured: Correct sequences/mean inter tap interval (ITI), percentage correct key presses/mean ITI, percentage correct sequences, percentage correct key presses, mean ITI, and mean correct sequences in the performance interval. Baseline, during training and POST (30 min after baseline) intervention No
See also
  Status Clinical Trial Phase
Recruiting NCT03144102 - Combining tDCS With VR-based Motor Training in Stroke N/A